Lv3
352 积分 2026-07-30 加入
Improving therapeutic strategies for triple-negative breast cancer: synergistic effects of DKC1 inhibition and paclitaxel
3天前
已完结
Interferon-induced senescent CD8 + T cells reduce anti-PD1 immunotherapy efficacy in early triple-negative breast cancer
1个月前
已完结
Activation of the γ-secretase/NICD-PXR/Notch pathway induces Taxol resistance in triple-negative breast cancer
1个月前
已完结
Dendritic cell-driven immune rebalancing as a systemic regulator of tumor and neurodegenerative microenvironments
1个月前
已关闭
Inducing ferroptosis in breast cancer with nanoparticles: a promising and challenging therapeutic strategy
1个月前
已完结
Genetic Silencing of CDC6 via AAV2-Delivered shRNA as a Novel Cancer Genetics–Based Therapy for Cervical Carcinoma
2个月前
已完结
The RB protein: more than a sentry of cell cycle entry
3个月前
已完结
CDC6: from DNA replication to cell cycle checkpoints and oncogenesis
3个月前
已完结
CRISPR Screens Identify POLB as a Synthetic Lethal Enhancer of PARP Inhibition Exclusively in BRCA-Mutated Tumors
3个月前
已完结
Drug-gene interaction screens coupled to tumour data analyses identify the most clinically-relevant cancer vulnerabilities driving sensitivity to PARP inhibition
3个月前
已关闭
皖公网安备34019202002308
